RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.


A collection of news and information related to Hepatitis published by this site and its partners.

Top Hepatitis Articles see all

Displaying items 1-5
  • Giving pricey hepatitis drug to prisoners may be financially wise

    NEW YORK (Reuters Health) - Using expensive new antivirals to treat hepatitis C in prisoners makes fiscal sense, a new paper says.
  • U.S. FDA approves Gilead's $94,500 hepatitis C drug

    (Reuters) - U.S. regulators on Friday approved a new hepatitis C pill from Gilead Sciences Inc, which said it will charge $94,500 for an improved 12-week course of treatment to rid patients of the liver-destroying viral infection. The daily pill, to be...

    U. of C. Medicine to take aim at hepatitis C

    U. of C. Medicine to take aim at hepatitis C
    University of Chicago Medicine will receive a $6.2 million grant from the Centers for Disease Control and Prevention to battle hepatitis C in Chicago, mounting an all-out assault on the disease, health care administrators will announce Thursday. About...

    Q&A: States and drug prices

    WASHINGTON The new hepatitis C drug Sovaldi promises a cure rate of well over 90 percent, compared with 45 percent (at best) for older drugs. But when Sovaldi went on the market earlier this year for as much as $84,000 for a single course of treatment,...

    France uses tax to put pressure on hepatitis C drug prices

    PARIS (Reuters) - France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices. The...